Clinical development strategy, tools and trial designs

CELL AND GENE THERAPY INSIGHTS

Clinical development strategy, tools and trial designs

June 2020
Clinical development strategy, tools and trial designs
Download PDF

Expert Insight

Cellular therapies for solid cancer: clinical experience, challenges and future revolution

Cellular therapies for solid cancer: clinical experience, challenges and future revolution

A Hasan, A Selvakumar, R O'Reilly et al.
1 July 2020
Read
Consideration of clinical translation of cardiac AAV gene therapy

Consideration of clinical translation of cardiac AAV gene therapy

Kelly P Yamada, Serena Tharakan, Kiyotake Ishikawa
14 May 2020
Read
Delivery methods for cardiovascular cell-based therapies: tools and clinical strategies

Delivery methods for cardiovascular cell-based therapies: tools and clinical strategies

Ruben A Alexanian, Amish N Raval
6 May 2020
Read
Clinical trial design in gene therapy for neurodegenerative diseases: Sanfilippo A syndrome

Clinical trial design in gene therapy for neurodegenerative diseases: Sanfilippo A syndrome

C R Plata-Salaman, A Morte, E Ortiz et al.
6 May 2020
Read

Interview

Progressing Bristol Myers Squibb’s clinical-stage pipeline of cellular cancer immunotherapies

Progressing Bristol Myers Squibb’s clinical-stage pipeline of cellular cancer immunotherapies

Stan Frankel
29 June 2020
Read
Targeting lung damage in COVID-19 patients with CD34<sup>+</sup> cell therapy

Targeting lung damage in COVID-19 patients with CD34+ cell therapy

Douglas Losordo
17 June 2020
Read
A streamlined approach to biomarker development in cellular immunotherapy

A streamlined approach to biomarker development in cellular immunotherapy

Majid Ghoddusi
1 June 2020
Read